The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. Learn more

The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. Learn more

BioSyntech logo
Exited company

BioSyntech

Details
Region
Quebec
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn more
About the company

BioSyntech was a medical device company specialized in the development, manufacturing and commercialization of advanced biotherapeutic thermogels for regenerative medicine (tissue repair) and therapeutic delivery. BioSyntech’s platform technology is a family of hydrogels called BST-Gel®.